menu
    • menu
    [{"orgOrder":0,"company":"Sitala Bio","sponsor":"Fosun Pharmaceutical","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"CHINA","productType":"Miscellaneous","year":"2025","type":"Licensing Agreement","leadProduct":"FXS6837","moa":"Undisclosed","graph1":"Immunology","graph2":"Phase II","graph3":"Sitala Bio","amount2":0.67000000000000004,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Immunology","amount2New":0.67000000000000004,"dosageForm":"Undisclosed","sponsorNew":"Sitala Bio \/ Sitala Bio","highestDevelopmentStatusID":"8","companyTruncated":"Sitala Bio \/ Sitala Bio"}]

    Find Clinical Drug Pipeline Developments & Deals by Sitala Bio

    Menu

    Sitala Bio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Sitala Bio

                            United Kingdom arrow
                            Bio-Europe Autumn
                            Not Confirmed

                            Sitala Bio

                            United Kingdom arrow
                            Bio-Europe Autumn
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : FXS6837

                            Therapeutic Area : Immunology

                            Study Phase : Phase II

                            Recipient : Fosun Pharmaceutical

                            Deal Size : $670.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Forbion, OrbiMed-backed Sitala seals $670M deal for Fosun immune disease drug

                            Details : Under the licensing agreement, Sitala will hold the right of FXS6837, which is being evaluated for the treatment of immune disease.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : $25.0 million

                            August 26, 2025

                            Lead Product(s) : FXS6837

                            Therapeutic Area : Immunology

                            Highest Development Status : Phase II

                            Recipient : Fosun Pharmaceutical

                            Deal Size : $670.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth